Načítá se...

Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases

BACKGROUND. Circulating tumor DNA (ctDNA) is a promising technology for treatment selection, prognostication, and surveillance after definitive therapy. Its use in the perioperative setting for patients with metastatic disease has not been well studied. We characterize perioperative plasma ctDNA and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: Baumgartner, Joel M., Riviere, Paul, Lanman, Richard B., Kelly, Kaitlyn J., Veerapong, Jula, Lowy, Andrew M., Kurzrock, Razelle
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470602/
https://ncbi.nlm.nih.gov/pubmed/32767050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08331-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!